Skip to main content
. 2016 Jun 7;7(27):42422–42430. doi: 10.18632/oncotarget.9880

Figure 5.

BAIAP2-AS1 was significantly silenced by siRNA 1# A. compared with negative control (NC). And after silence of BAIAP2-AS1, the expression levels of MAPKAP1 and RAF1 decreased, while E2F3 showed no significant differences B. *P<0.05, **<P<0.01.

Figure 5